China Pediatric Pharmaceuticals, Inc. Receivables Turnover Ratio (CPDU), from the first quarter 2014 to the first quarter 2013 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
China Pediatric Pharmaceuticals, Inc.  (CPDU)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

China Pediatric Pharmaceuticals Accounts Receivables Turnover Ratio from the first quarter 2014 to the first quarter 2013

Quarterly Results, Trends, Rankings, Statistics


China Pediatric Pharmaceuticals, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2014 to a ratio of 1.48, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the first quarter 2014. Average receivable collection period, for the China Pediatric Pharmaceuticals in Mar 31 2014 quarter, has decreased to 247 days, compared to 304 days, in the Dec 31 2013 quarter.

If we take a look into Healthcare sector 319 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2014 from 3136 to 3452.

What is Receivable Turnover Ratio?
What is China Pediatric Pharmaceuticals, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CPDU Receivables Turnover Ratio (Mar 31 2014)
I. Quarter		 (Dec 31 2013)
IV. Quarter		 (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter
Y / Y Receivable Change -25.67 % 42.67 % -78.96 % -86.19 % -85.21 %
Y / Y Revenue Change 79.17 % -7.44 % -59.91 % -84.82 % -81.74 %
Receivable Turnover Ratio (TTM) 1.48 1.2 1.47 1.1 1.44
CPDU's Total Ranking # 3452 # 3136 # 3001 # 1957 # 1811
Accounts Receivable average collection period days 247 305 249 332 254
Seq. Receivable Change -79.55 % 233.47 % 24.56 % -12.5 % -60.75 %
Seq. Revenue Change 40.85 % 42.83 % -15.96 % 5.98 % -27.23 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 30
Healthcare Sector # 320
Overall Market # 3452

Receivable Turnover Ratio Statistics
High Average Low
1.51 1.27 0.94
(Mar 31 2012)   (Mar 31 2014)





CPDU Company Profile • Back to CPDU Efficiency Comparisons • Compare CPDU Receivables Turnover Ratio to its Competitors

Financial Statements
China Pediatric Pharmaceuticals's Accounts Receivable $ 1 Millions Visit CPDU's Balance sheet
China Pediatric Pharmaceuticals's Sales TTM $ 4 Millions Visit CPDU's Income Statement
Sources of CPDU's Revenues Visit CPDU's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CPDU's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CPDU's Growth Rates CPDU's Roa CPDU's Inventory Turnover Ratio CPDU's Dividend Comparisons
CPDU's Profitability Ratios CPDU's Roi CPDU's Asset Turnover Ratio CPDU's Dividend Growth
CPDU's Valuation Ratios CPDU's Roe CPDU's Financial Strength Ratios CPDU's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2014, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2014 Receivable at quarter ending Mar 31 2014
Encompass Health Corporation  8.64 $ 2,291.800  Millions$ 265.400  Millions
Immunomedics Inc   8.58 $ 9.217  Millions$ 1.075  Millions
Dendreon Corp  8.57 $ 284.932  Millions$ 33.257  Millions
Biogen Inc   8.51 $ 7,646.854  Millions$ 898.937  Millions
Ensign Group Inc  8.48 $ 937.059  Millions$ 110.451  Millions
Jazz Pharmaceuticals Plc  8.41 $ 986.799  Millions$ 117.337  Millions
Vivus Inc  8.27 $ 113.661  Millions$ 13.742  Millions
Abiomed Inc   8.22 $ 183.643  Millions$ 22.354  Millions
Allergan plc  8.20 $ 7,581.500  Millions$ 924.775  Millions
Atrion Corporation  8.16 $ 134.919  Millions$ 16.529  Millions
Cas Medical Systems Inc  8.08 $ 22.051  Millions$ 2.729  Millions
Inotiv Inc   8.06 $ 23.241  Millions$ 2.882  Millions
Axogen inc   8.03 $ 14.086  Millions$ 1.754  Millions
Star Equity Holdings Inc   8.02 $ 50.556  Millions$ 6.307  Millions
Utah Medical Products Inc  7.97 $ 39.946  Millions$ 5.012  Millions
Insite Vision Inc  7.95 $ 26.715  Millions$ 3.360  Millions
Genmark Diagnostics Inc   7.93 $ 24.216  Millions$ 3.054  Millions
Edwards Lifesciences Corporation  7.88 $ 2,567.900  Millions$ 325.675  Millions
Bio techne Corp  7.87 $ 344.715  Millions$ 43.809  Millions
Clearday Inc   7.86 $ 1.323  Millions$ 0.168  Millions
Pediatrix Medical Group Inc   7.86 $ 2,247.216  Millions$ 285.919  Millions
Biocryst Pharmaceuticals Inc   7.84 $ 17.235  Millions$ 2.197  Millions
Camp4 Therapeutics Corporation  7.81 $ 235.903  Millions$ 30.215  Millions
Heska Corporation  7.75 $ 80.153  Millions$ 10.342  Millions
Meridian Bioscience Inc   7.71 $ 189.301  Millions$ 24.545  Millions
Seagen Inc   7.69 $ 280.207  Millions$ 36.426  Millions
Quest Diagnostics Inc  7.69 $ 7,104.840  Millions$ 924.138  Millions
Patterson Companies Inc   7.68 $ 4,063.715  Millions$ 529.116  Millions
Masimo Corp  7.66 $ 551.117  Millions$ 71.990  Millions
Milestone Scientific Inc   7.61 $ 10.503  Millions$ 1.380  Millions

Date modified: 2026-06-22T14:31:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.